ARQT Arcutis Biotherapeutics Inc

USD 9.77 -0.50 -4.868549
Icon

Arcutis Biotherapeutics Inc (ARQT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 9.77

-0.50 (-4.87)%

USD 1.19B

2.23M

USD 17.20(+76.05%)

N/A

Icon

ARQT

Arcutis Biotherapeutics Inc (USD)
COMMON STOCK | NSD
USD 9.77
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.19B

N/A

USD 9.77

Arcutis Biotherapeutics Inc (ARQT) Stock Forecast

Show ratings and price targets of :
USD 17.20
(+76.05%)

Based on the Arcutis Biotherapeutics Inc stock forecast from 2 analysts, the average analyst target price for Arcutis Biotherapeutics Inc is USD 17.20 over the next 12 months. Arcutis Biotherapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Arcutis Biotherapeutics Inc is Bearish, which is based on 3 positive signals and 8 negative signals. At the last closing, Arcutis Biotherapeutics Inc’s stock price was USD 9.77. Arcutis Biotherapeutics Inc’s stock price has changed by -8.95% over the past week, +19.88% over the past month and -7.74% over the last year.

No recent analyst target price found for Arcutis Biotherapeutics Inc
No recent average analyst rating found for Arcutis Biotherapeutics Inc

Company Overview Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaqu...Read More

https://www.arcutis.com

3027 Townsgate Road, Westlake Village, CA, United States, 91361

296

December

USD

USA

Adjusted Closing Price for Arcutis Biotherapeutics Inc (ARQT)

Loading...

Unadjusted Closing Price for Arcutis Biotherapeutics Inc (ARQT)

Loading...

Share Trading Volume for Arcutis Biotherapeutics Inc Shares

Loading...

Compare Performance of Arcutis Biotherapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ARQT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Arcutis Biotherapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -0.25 (-0.05%) USD127.00B 31.94 20.00

ETFs Containing ARQT

Symbol Name ARQT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Arcutis Biotherapeutics Inc (ARQT) Stock

Based on ratings from 2 analysts Arcutis Biotherapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 5 buy, sell and hold ratings.

Unfortunately we do not have enough data on ARQT's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for ARQT is USD 17.20 over the next 12 months. The maximum analyst target price is USD 18 while the minimum anlayst target price is USD 16.

ARQT stock's Price/Earning ratio is -99,999.99. Our analysis grades ARQT stock's Price / Earning ratio at A-. This means that ARQT stock's Price/Earning ratio is above 7.999999999999996% of the stocks in the Biotechnology sector in the NSD exchange. Based on this ARQT may be undervalued for its sector.

The last closing price of ARQT's stock was USD 9.77.

The most recent market capitalization for ARQT is USD 1.19B.

Based on targets from 2 analysts, the average taret price for ARQT is projected at USD 17.20 over the next 12 months. This means that ARQT's stock price may go up by +76.05% over the next 12 months.

We can't find any ETFs which contains Arcutis Biotherapeutics Inc's stock.

As per our most recent records Arcutis Biotherapeutics Inc has 296 Employees.

Arcutis Biotherapeutics Inc's registered address is 3027 Townsgate Road, Westlake Village, CA, United States, 91361. You can get more information about it from Arcutis Biotherapeutics Inc's website at https://www.arcutis.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...